Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

9.53

-0.28 (-2.85%)

At close: Oct 26, 2026, 4:00 PM EDT

9.51

-0.02 (-0.21%)

Pre-market: Oct 27, 2026, 7:22 AM EDT

Zevra Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	566	504	445	272	158	308
Market Cap Growth	-6.30%	13.31%	63.82%	71.57%	-48.52%	536.60%
Enterprise Value	346	368	416	233	97	178
Last Close Price	9.53	8.96	8.34	6.55	4.59	8.71

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	9.92	6.50	-	-	-	-
Forward PE	11.17	19.15	102.50	102.50	102.50	24.17
PS Ratio	4.16	4.74	18.85	9.90	15.59	10.74
PB Ratio	2.60	3.26	11.22	4.39	2.11	2.42
P/TBV Ratio	2.73	3.51	-	-	2.11	2.42
P/FCF Ratio	17.35	-	-	-	-	29.76
P/OCF Ratio	16.94	-	-	-	-	29.47

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.54	3.45	17.61	8.49	9.52	6.21
EV/EBITDA Ratio	8.53	-	-	-	-	22.27
EV/EBIT Ratio	8.85	-	-	-	-	23.01
EV/FCF Ratio	10.60	-	-	-	-	17.20

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.41	1.52	0.71	0.19	0.01
Debt / EBITDA Ratio	0.04	92.54	-	-	-	0.18
Debt / FCF Ratio	0.05	-	-	-	-	0.16
Net Debt / Equity Ratio	-1.01	-0.83	-0.23	-0.39	-0.91	-0.87
Net Debt / EBITDA Ratio	-5.43	713.99	0.11	0.49	2.87	-13.87
Net Debt / FCF Ratio	-6.75	52.53	0.13	0.71	3.65	-10.71
Asset Turnover	0.49	0.46	0.14	0.19	0.08	0.40
Inventory Turnover	3.48	8.89	-	-	-	-
Quick Ratio	5.02	5.46	2.35	1.16	7.58	26.92
Current Ratio	5.17	5.68	2.53	1.18	7.72	27.20
Return on Equity (ROE)	34.80%	85.66%	-207.84%	-67.23%	-26.48%	-28.18%
Return on Assets (ROA)	8.74%	-1.14%	-31.03%	-21.55%	-12.54%	6.70%
Return on Invested Capital (ROIC)	1679.05%	-14.18%	-254.55%	-223.98%	-218.60%	77.08%
Return on Capital Employed (ROCE)	15.40%	-1.70%	-60.40%	-50.30%	-24.10%	6.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	10.08%	16.50%	-23.70%	-16.95%	-16.90%	-2.78%
FCF Yield	5.76%	-0.48%	-15.65%	-12.45%	-11.88%	3.36%
Buyback Yield / Dilution	-13.46%	-23.81%	-30.46%	-2.79%	-15.87%	-647.72%

SEC Filings: 10-K · 10-Q